MICROWAVE ABLATION IN COMBINED TREATMENT OF PRIMARY AND METASTATIC LIVER TUMORS

Abstract

Aim. To increase the effectiveness of treatment of patients with primary and metastatic liver cancer. Material and Methods. Microwave ablation was performed in 29 patients including 13 cases of hepatocellular carcinoma stage 0-A (byBarcelona classification and TNM) and 16 patients with colorectal cancer and liver metastases stage I (by Gennari). For microwave ablation of liver tumors AveCure MWG881 (MedWaves) device was used. Procedure was performed via percutaneous transhepatic approach (25), under ultrasonic guidance and intraoperatively simultaneously with liver resection in 4 cases. Effectiveness was estimated using CT and sonography. Results. There were no deaths. We observed following complications: moderate bleeding from the point of needle catheter entry that has stopped independently in 1 case; residual cavity formed in one case that did not require additional surgery. Intrahepatic hematoma was diagnosed in 1 case. Burns of the skin were revealed in 2 cases. The average hospital stay was 7 days. Local recurrences after ablation were not observed. 1- and 2-year survival was 78.5% and 63.3% respectively. Conclusion. Microwave ablation in patients with primary and secondary liver cancer and concomitant cirrhosis increases 1- and 2-year survival. Percutaneous microwave ablation reduces the incidence of complications in high risk patients due to low invasiveness and less trauma.